Efficient RT-QuIC seeding activity for α-synuclein in olfactory mucosa samples of patients with Parkinson's disease and multiple system atrophy.
Neurodegenerative parkinsonisms
Olfactory mucosa
Parkinson’s disease
RT-QuIC
α-Synuclein
Journal
Translational neurodegeneration
ISSN: 2047-9158
Titre abrégé: Transl Neurodegener
Pays: England
ID NLM: 101591861
Informations de publication
Date de publication:
2019
2019
Historique:
received:
19
02
2019
accepted:
18
07
2019
entrez:
14
8
2019
pubmed:
14
8
2019
medline:
14
8
2019
Statut:
epublish
Résumé
Parkinson's disease (PD) is a neurodegenerative disorder whose diagnosis is often challenging because symptoms may overlap with neurodegenerative parkinsonisms. PD is characterized by intraneuronal accumulation of abnormal α-synuclein in brainstem while neurodegenerative parkinsonisms might be associated with accumulation of either α-synuclein, as in the case of Multiple System Atrophy (MSA) or tau, as in the case of Corticobasal Degeneration (CBD) and Progressive Supranuclear Palsy (PSP), in other disease-specific brain regions. Definite diagnosis of all these diseases can be formulated only neuropathologically by detection and localization of α-synuclein or tau aggregates in the brain. Compelling evidence suggests that trace-amount of these proteins can appear in peripheral tissues, including receptor neurons of the olfactory mucosa (OM). We have set and standardized the experimental conditions to extend the ultrasensitive Real Time Quaking Induced Conversion (RT-QuIC) assay for OM analysis. In particular, by using human recombinant α-synuclein as substrate of reaction, we have assessed the ability of OM collected from patients with clinical diagnoses of PD and MSA to induce α-synuclein aggregation, and compared their seeding ability to that of OM samples collected from patients with clinical diagnoses of CBD and PSP. Our results showed that a significant percentage of MSA and PD samples induced α-synuclein aggregation with high efficiency, but also few samples of patients with the clinical diagnosis of CBD and PSP caused the same effect. Notably, the final RT-QuIC aggregates obtained from MSA and PD samples owned peculiar biochemical and morphological features potentially enabling their discrimination. Our study provide the proof-of-concept that olfactory mucosa samples collected from patients with PD and MSA possess important seeding activities for α-synuclein. Additional studies are required for (i) estimating sensitivity and specificity of the technique and for (ii) evaluating its application for the diagnosis of PD and neurodegenerative parkinsonisms. RT-QuIC analyses of OM and cerebrospinal fluid (CSF) can be combined with the aim of increasing the overall diagnostic accuracy of these diseases, especially in the early stages.
Sections du résumé
BACKGROUND
BACKGROUND
Parkinson's disease (PD) is a neurodegenerative disorder whose diagnosis is often challenging because symptoms may overlap with neurodegenerative parkinsonisms. PD is characterized by intraneuronal accumulation of abnormal α-synuclein in brainstem while neurodegenerative parkinsonisms might be associated with accumulation of either α-synuclein, as in the case of Multiple System Atrophy (MSA) or tau, as in the case of Corticobasal Degeneration (CBD) and Progressive Supranuclear Palsy (PSP), in other disease-specific brain regions. Definite diagnosis of all these diseases can be formulated only neuropathologically by detection and localization of α-synuclein or tau aggregates in the brain. Compelling evidence suggests that trace-amount of these proteins can appear in peripheral tissues, including receptor neurons of the olfactory mucosa (OM).
METHODS
METHODS
We have set and standardized the experimental conditions to extend the ultrasensitive Real Time Quaking Induced Conversion (RT-QuIC) assay for OM analysis. In particular, by using human recombinant α-synuclein as substrate of reaction, we have assessed the ability of OM collected from patients with clinical diagnoses of PD and MSA to induce α-synuclein aggregation, and compared their seeding ability to that of OM samples collected from patients with clinical diagnoses of CBD and PSP.
RESULTS
RESULTS
Our results showed that a significant percentage of MSA and PD samples induced α-synuclein aggregation with high efficiency, but also few samples of patients with the clinical diagnosis of CBD and PSP caused the same effect. Notably, the final RT-QuIC aggregates obtained from MSA and PD samples owned peculiar biochemical and morphological features potentially enabling their discrimination.
CONCLUSIONS
CONCLUSIONS
Our study provide the proof-of-concept that olfactory mucosa samples collected from patients with PD and MSA possess important seeding activities for α-synuclein. Additional studies are required for (i) estimating sensitivity and specificity of the technique and for (ii) evaluating its application for the diagnosis of PD and neurodegenerative parkinsonisms. RT-QuIC analyses of OM and cerebrospinal fluid (CSF) can be combined with the aim of increasing the overall diagnostic accuracy of these diseases, especially in the early stages.
Identifiants
pubmed: 31406572
doi: 10.1186/s40035-019-0164-x
pii: 164
pmc: PMC6686411
doi:
Types de publication
Journal Article
Langues
eng
Pagination
24Déclaration de conflit d'intérêts
Competing interestsThe authors declare that they have no competing interests.
Références
Neurology. 1999 Oct 12;53(6):1292-9
pubmed: 10522887
Neurology. 2001 Oct 23;57(8):1497-9
pubmed: 11673599
J Neuropsychiatry Clin Neurosci. 2002 Spring;14(2):223-36; discussion 222
pubmed: 11983801
J Neurol. 2002 Feb;249(2):138-45
pubmed: 11985378
Acta Neuropathol. 2002 Sep;104(3):273-8
pubmed: 12172913
Mov Disord. 2003 Sep;18 Suppl 6:S2-12
pubmed: 14502650
J Neurochem. 2004 Feb;88(4):800-12
pubmed: 14756800
Mov Disord. 2004 Feb;19(2):181-9
pubmed: 14978673
Mov Disord. 2004 Jun;19(6):630-40
pubmed: 15197700
J Neurol Neurosurg Psychiatry. 2004 Dec;75(12):1749-52
pubmed: 15548497
J Struct Biol. 2005 Sep;151(3):229-38
pubmed: 16125973
J Neurol Neurosurg Psychiatry. 2006 Feb;77(2):275-6
pubmed: 16421140
J Neuropathol Exp Neurol. 2006 Apr;65(4):387-95
pubmed: 16691119
Science. 1991 Jun 14;252(5012):1515-22
pubmed: 1675487
J Neuropathol Exp Neurol. 2006 Jul;65(7):685-97
pubmed: 16825955
Neurochem Res. 2006 Sep;31(9):1153-62
pubmed: 16947080
Science. 2007 Nov 9;318(5852):930-6
pubmed: 17991853
Nat Methods. 2008 Mar;5(3):211-2
pubmed: 18309304
Neurology. 2008 Aug 26;71(9):670-6
pubmed: 18725592
PLoS One. 2008 Sep 04;3(9):e3135
pubmed: 18769546
Curr Protein Pept Sci. 2009 Oct;10(5):483-99
pubmed: 19538146
Proc Natl Acad Sci U S A. 2009 Aug 4;106(31):13010-5
pubmed: 19651612
Nat Rev Neurosci. 2010 Mar;11(3):155-9
pubmed: 20029438
Ann Neurol. 2010 Apr;67(4):462-9
pubmed: 20437581
J Neurosci. 2010 May 26;30(21):7281-9
pubmed: 20505094
Int J Biochem Cell Biol. 2010 Nov;42(11):1775-8
pubmed: 20678581
Neurosci Lett. 2010 Nov 26;485(3):222-7
pubmed: 20849919
Neuropathology. 2011 Jun;31(3):299-305
pubmed: 21062361
Nat Med. 2011 Feb;17(2):175-8
pubmed: 21278748
Prion. 2011 Jul-Sep;5(3):150-3
pubmed: 21778820
J Neurochem. 2012 Sep;122(5):883-90
pubmed: 22734715
Cold Spring Harb Perspect Med. 2012 Aug 01;2(8):null
pubmed: 22908195
Ann Neurol. 2012 Oct;72(4):517-24
pubmed: 23109146
Neurology. 2013 Jan 29;80(5):496-503
pubmed: 23359374
Hum Pathol. 1988 Jan;19(1):27-31
pubmed: 2447008
Nat Med. 2014 Feb;20(2):130-8
pubmed: 24504409
J Neurol Neurosurg Psychiatry. 2014 Aug;85(8):925-9
pubmed: 24521567
PLoS One. 2014 Mar 11;9(3):e90857
pubmed: 24618582
Cell Rep. 2014 Apr 10;7(1):261-8
pubmed: 24656814
J Biol Chem. 2014 Jul 18;289(29):19855-61
pubmed: 24860099
BMC Neurosci. 2014 Jun 04;15:69
pubmed: 24898419
Neurology. 2014 Jul 29;83(5):406-12
pubmed: 24975862
N Engl J Med. 2014 Aug 7;371(6):519-29
pubmed: 25099576
J Neurol. 2014 Nov;261(11):2209-17
pubmed: 25209854
Nature. 2015 Jun 18;522(7556):340-4
pubmed: 26061766
Neurology. 2015 Aug 4;85(5):404-12
pubmed: 26138942
J Parkinsons Dis. 2015;5(2):269-79
pubmed: 26405788
Mov Disord. 2015 Oct;30(12):1591-601
pubmed: 26474316
Neurology. 2016 Feb 9;86(6):566-76
pubmed: 26764028
J Vis Exp. 2016 Jan 05;(107):null
pubmed: 26780369
Dtsch Arztebl Int. 2016 Feb 5;113(5):61-9
pubmed: 26900156
J Neurochem. 2016 Oct;139 Suppl 1:256-274
pubmed: 26924014
Am J Alzheimers Dis Other Demen. 2016 Nov;31(7):585-594
pubmed: 27295974
Continuum (Minneap Minn). 2016 Aug;22(4 Movement Disorders):1117-42
pubmed: 27495201
Neurol Clin. 2016 Nov;34(4):955-965
pubmed: 27720003
Ann Clin Transl Neurol. 2016 Aug 28;3(10):812-818
pubmed: 27752516
JAMA Neurol. 2017 Feb 1;74(2):163-172
pubmed: 27918765
Acta Neuropathol. 2017 May;133(5):751-765
pubmed: 28293793
Sci Rep. 2017 Apr 07;7:46269
pubmed: 28387370
Acta Neuropathol. 2017 Aug;134(2):187-205
pubmed: 28401333
Mov Disord. 2017 Jun;32(6):853-864
pubmed: 28467028
Biol Psychiatry. 2018 Feb 15;83(4):337-346
pubmed: 28506438
Neurobiol Dis. 2018 Jan;109(Pt B):209-218
pubmed: 28751258
Parkinsonism Relat Disord. 2018 Jan;46 Suppl 1:S30-S33
pubmed: 28780180
Acta Neuropathol. 2018 Jan;135(1):49-63
pubmed: 28849371
Auton Neurosci. 2018 May;211:15-25
pubmed: 29111419
Nat Commun. 2017 Nov 10;8(1):1434
pubmed: 29127332
Sci Transl Med. 2017 Nov 22;9(417):null
pubmed: 29167394
Neuron. 2018 Jan 3;97(1):92-107.e10
pubmed: 29290548
Acta Neuropathol Commun. 2018 Feb 9;6(1):7
pubmed: 29422107
Cell Tissue Res. 2018 Jul;373(1):195-212
pubmed: 29704213
Handb Clin Neurol. 2018;153:357-370
pubmed: 29887145
Neurology. 2018 Jul 17;91(3):e268-e279
pubmed: 29898972
Regen Med. 2018 Jul 1;13(5):581-593
pubmed: 30113240
Arch Pathol Lab Med. 1986 Dec;110(12):1160-3
pubmed: 3022672
Metallomics. 2019 Jan 23;11(1):128-140
pubmed: 30465671
J Biol Chem. 2019 Jan 18;294(3):1045-1058
pubmed: 30478174
Parkinsonism Relat Disord. 2019 Feb;59:74-81
pubmed: 30502095
Ann Neurol. 2019 May;85(5):777-781
pubmed: 30801759
Ann Neurol. 2019 May;85(5):691-703
pubmed: 30805957
Neurosci Lett. 1993 Nov 12;162(1-2):179-82
pubmed: 8121624
Neurology. 1996 Jul;47(1):1-9
pubmed: 8710059
Brain. 1997 Jan;120 ( Pt 1):65-74
pubmed: 9055798
Neurosci Lett. 1997 Jul 11;230(1):49-52
pubmed: 9259461
Arch Neurol. 1997 Aug;54(8):937-44
pubmed: 9267967